Previous studies have shown that FHL1 binds the oestrogen receptor transcription factor to regulate breast cancer cell growth and that the binding of FHL2 to the transcription factor E4F1 inhibits its transcriptional regulation and promotes cell proliferation [41, 43]. Here, FHL2 is linked to breast carcinoma.